Business · 21/12/2018Updated: 10/17/2026 · 1 min read
FDA Announces Final Guidance on Labeling Red Blood Cell Units with Historical Antigen Typing Results
Summary
The Food and Drug Administration (FDA) has released a final guidance document providing recommendations for labeling Red Blood Cell units with historical antigen typing results, which will help transfusion services manage these units and ensure compliance with biologics regulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →